<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02137304</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A01771-44</org_study_id>
    <nct_id>NCT02137304</nct_id>
  </id_info>
  <brief_title>A Method to Optimize Mecanical In-exsufflation in Neuromuscular Diseases</brief_title>
  <acronym>COUGHELP</acronym>
  <official_title>A Method to Optimize Mecanical In-exsufflation in Neuromuscular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to demonstrate that there is an optimal expiratory pressure when using
      mecanical in-exsufflation for each patient in neuromuscular disease. This compromise is
      between the need to generate a high pressure difference between alveoli and the mouth and the
      need to avoide and superior airways collapsus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      he investigators want to demonstrate that there is an optimal expiratory pressure when using
      mecanical in-exsufflation for each patient in neuromuscular disease. This compromise is
      between the need to generate a high pressure difference between alveoli and the mouth and the
      need to avoide and superior airways collapsus.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 4, 2014</start_date>
  <completion_date type="Actual">September 8, 2017</completion_date>
  <primary_completion_date type="Actual">September 8, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>optimal negative pressure treshold value</measure>
    <time_frame>20 minutes</time_frame>
    <description>Optimal negative pressure treshold value measured for a flow superior or equal to 160 liter/minute and 270 liter/minute</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>optimal pressure treshold based on the best peak flow.</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>volume-flow curve aspect</measure>
    <time_frame>5 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Neuromuscular Disease</condition>
  <arm_group>
    <arm_group_label>neuromuscular patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA)</intervention_name>
    <description>Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA) mechanical insufflation to increase peak cough flow</description>
    <arm_group_label>neuromuscular patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  man or female age18 years

          -  neuromuscular disease

          -  coughassist adaptation treatment

          -  peak cough flow&lt;270liter/minute

        Exclusion Criteria:

          -  acute organ failure

          -  insufflation contrindication

          -  pregnant women/no affiliation to a social security scheme

          -  plan of legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederic LOFASO, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP-HP Hopital R. Poincaré Garches</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital R. POINCARE</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2014</study_first_submitted>
  <study_first_submitted_qc>May 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2014</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cough help</keyword>
  <keyword>in-exsufflation</keyword>
  <keyword>neuromuscular disease</keyword>
  <keyword>cough assistance optimization</keyword>
  <keyword>efficient cough flow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

